Identification of HSP90 inhibitors as a novel class of senolytics
The accumulation of senescent cells is thought to contribute to the age-associated decline in tissue function. Here, the authors identify HSP90 inhibitors as a new class of senolytic compounds in an in vitro screening and show that administration of a HSP90 inhibitor reduces age-related symptoms in...
Guardado en:
Autores principales: | Heike Fuhrmann-Stroissnigg, Yuan Yuan Ling, Jing Zhao, Sara J. McGowan, Yi Zhu, Robert W. Brooks, Diego Grassi, Siobhan Q. Gregg, Jennifer L. Stripay, Akaitz Dorronsoro, Lana Corbo, Priscilla Tang, Christina Bukata, Nadja Ring, Mauro Giacca, Xuesen Li, Tamara Tchkonia, James L. Kirkland, Laura J. Niedernhofer, Paul D. Robbins |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6370fcbecaf7452cab92818e472747d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
por: Jasper Iske, et al.
Publicado: (2020) -
Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
por: Songhyun Lim, et al.
Publicado: (2021) -
Senolytics: A Novel Strategy for Neuroprotection in ALS?
por: Alexandra Maximova, et al.
Publicado: (2021) -
Identification and characterization of Cardiac Glycosides as senolytic compounds
por: Francisco Triana-Martínez, et al.
Publicado: (2019) -
Evaluating the neuroprotective impact of senolytic drugs on human vision
por: Nevin W. El-Nimri, et al.
Publicado: (2020)